[Prostacyclin; clinical aspects].
D000787:Angina Pectoris / Q000188:drug therapy; D001161:Arteriosclerosis / Q000188:drug therapy; D001688:Biological Products / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System; D003925:Diabetic Angiopathies / Q000188:drug therapy; D011464:Epoprostenol / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D005112:Extracorporeal Circulation; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000378:metabolism; D006801:Humans; D019746:Intramolecular Oxidoreductases; D010974:Platelet Aggregation / Q000187:drug effects; D011225:Pre-Eclampsia / Q000378:metabolism; D011247:Pregnancy; D011453:Prostaglandins / Q000502:physiology*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000378:metabolism; D011928:Raynaud Disease / Q000188:drug therapy
D001688:Biological Products; D011453:Prostaglandins; D003577:Cytochrome P-450 Enzyme System; D011464:Epoprostenol; D019746:Intramolecular Oxidoreductases; C022461:prostacyclin synthetase
Prostacycline; klinische aspecten.